| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH23 PFKP PTPRT CNTN6 MPRIP FASN EEF2 PTPN11 PTPRD PTPRF PKP3 DCHS1 SCRIB TNXB | 1.40e-04 | 599 | 147 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | methenyltetrahydrofolate cyclohydrolase activity | 1.61e-04 | 3 | 147 | 2 | GO:0004477 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase (NAD+) activity | 1.61e-04 | 3 | 147 | 2 | GO:0004487 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.12e-04 | 339 | 147 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.46e-04 | 17 | 147 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.46e-04 | 17 | 147 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 3.20e-04 | 4 | 147 | 2 | GO:0004486 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 3.20e-04 | 4 | 147 | 2 | GO:0004488 | |
| GeneOntologyMolecularFunction | cyclohydrolase activity | 5.31e-04 | 5 | 147 | 2 | GO:0019238 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 6.70e-04 | 54 | 147 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 7.92e-04 | 6 | 147 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 9.91e-04 | 103 | 147 | 5 | GO:0004725 | |
| GeneOntologyMolecularFunction | calcium ion binding | FLG FKBP10 NAALADL1 SYT12 PCDHGA3 CDH23 FLG2 RYR2 CELSR1 CADPS TCHHL1 DCHS1 PRRG3 PCDHGA8 | 1.29e-03 | 749 | 147 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.33e-03 | 110 | 147 | 5 | GO:0008238 | |
| GeneOntologyMolecularFunction | insulin receptor binding | 1.37e-03 | 30 | 147 | 3 | GO:0005158 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHGA3 CDH23 WNK1 PTPRT CNTN6 CELSR1 PTPRD PTPRF PTPRS DCHS1 PCDHGA8 | 1.37e-05 | 313 | 145 | 11 | GO:0098742 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 SYT12 RUSC1 MPDZ GRIA1 CAMK1 PTPRT SLC6A9 PTPRD PTPRF PTPRS ARC SCRIB KCNT1 | 2.01e-05 | 523 | 147 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 RUSC1 MPDZ GRIA1 CAMK1 PTPRT SLC6A9 PTPRF PTPRS ARC SCRIB KCNT1 | 8.52e-05 | 451 | 147 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | excitatory synapse | 1.10e-04 | 107 | 147 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.25e-04 | 157 | 147 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 RUSC1 MPDZ GRIA1 CAMK1 PTPRT SLC6A9 PTPRF PTPRS ARC SCRIB KCNT1 | 1.44e-04 | 477 | 147 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 RUSC1 MPDZ GRIA1 CAMK1 PTPRT SLC6A9 PTPRF PTPRS ARC SCRIB KCNT1 | 2.35e-04 | 503 | 147 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | keratohyalin granule | 4.84e-04 | 5 | 147 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.61e-04 | 201 | 147 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.01e-04 | 405 | 147 | 10 | GO:0045211 | |
| GeneOntologyCellularComponent | synaptic membrane | GRIA1 NBEA PTPRT CNTN6 SLC6A9 PTPRD PTPRF PTPRS ARC SCRIB CADPS2 KCNT1 | 8.71e-04 | 583 | 147 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 9.60e-04 | 107 | 147 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 9.60e-04 | 107 | 147 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | desmosome | 9.81e-04 | 28 | 147 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | cornified envelope | 1.42e-03 | 69 | 147 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | actomyosin | 1.43e-03 | 117 | 147 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.49e-03 | 118 | 147 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 CNTNAP1 MPDZ GRIA1 NBEA CAMK1 PTPRT EEF2 PTPRD CADPS PTPRS ARC SCRIB CADPS2 | 1.90e-03 | 817 | 147 | 14 | GO:0098978 |
| Domain | PTPc | 8.74e-06 | 36 | 147 | 5 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.31e-05 | 39 | 147 | 5 | PS50055 | |
| Domain | PTPase_domain | 1.68e-05 | 41 | 147 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 1.68e-05 | 41 | 147 | 5 | PF00102 | |
| Domain | CAPS | 6.15e-05 | 2 | 147 | 2 | IPR033227 | |
| Domain | Filaggrin | 6.15e-05 | 2 | 147 | 2 | IPR003303 | |
| Domain | PTPc_motif | 1.00e-04 | 59 | 147 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.00e-04 | 59 | 147 | 5 | IPR003595 | |
| Domain | THF_DHG_CYH_1 | 1.84e-04 | 3 | 147 | 2 | PS00766 | |
| Domain | THF_DHG_CYH_2 | 1.84e-04 | 3 | 147 | 2 | PS00767 | |
| Domain | THF_DH/CycHdrlase_CS | 1.84e-04 | 3 | 147 | 2 | IPR020867 | |
| Domain | Tyr_Pase_AS | 2.76e-04 | 73 | 147 | 5 | IPR016130 | |
| Domain | THF_DHG_CYH_C | 3.65e-04 | 4 | 147 | 2 | PF02882 | |
| Domain | THF_DH/CycHdrlase_cat_dom | 3.65e-04 | 4 | 147 | 2 | IPR020630 | |
| Domain | THF_DH/CycHdrlase_NAD-bd_dom | 3.65e-04 | 4 | 147 | 2 | IPR020631 | |
| Domain | THF_DHG_CYH | 3.65e-04 | 4 | 147 | 2 | PF00763 | |
| Domain | THF_DH/CycHdrlase | 3.65e-04 | 4 | 147 | 2 | IPR000672 | |
| Domain | TYR_PHOSPHATASE_1 | 5.89e-04 | 86 | 147 | 5 | PS00383 | |
| Domain | DUF1041 | 6.06e-04 | 5 | 147 | 2 | SM01145 | |
| Domain | TYR_PHOSPHATASE_dom | 6.21e-04 | 87 | 147 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 6.21e-04 | 87 | 147 | 5 | PS50056 | |
| Domain | Ig_I-set | 7.76e-04 | 190 | 147 | 7 | IPR013098 | |
| Domain | I-set | 7.76e-04 | 190 | 147 | 7 | PF07679 | |
| Domain | - | 8.01e-04 | 92 | 147 | 5 | 3.90.190.10 | |
| Domain | TFR_dimer | 9.04e-04 | 6 | 147 | 2 | PF04253 | |
| Domain | - | 9.04e-04 | 6 | 147 | 2 | 1.20.930.40 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.11e-03 | 99 | 147 | 5 | IPR029021 | |
| Domain | S100_CABP | 1.22e-03 | 27 | 147 | 3 | PS00303 | |
| Domain | S_100 | 1.22e-03 | 27 | 147 | 3 | PF01023 | |
| Domain | Munc13_1 | 1.26e-03 | 7 | 147 | 2 | IPR014770 | |
| Domain | MHD1 | 1.26e-03 | 7 | 147 | 2 | PS51258 | |
| Domain | TFR-like_dimer_dom | 1.26e-03 | 7 | 147 | 2 | IPR007365 | |
| Domain | DUF1041 | 1.26e-03 | 7 | 147 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.26e-03 | 7 | 147 | 2 | IPR010439 | |
| Domain | S100_Ca-bd_sub | 1.35e-03 | 28 | 147 | 3 | IPR013787 | |
| Domain | S_100 | 1.35e-03 | 28 | 147 | 3 | SM01394 | |
| Domain | FBG | 1.50e-03 | 29 | 147 | 3 | SM00186 | |
| Domain | - | 1.66e-03 | 30 | 147 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.66e-03 | 30 | 147 | 3 | IPR014716 | |
| Domain | Cadherin_CS | 1.71e-03 | 109 | 147 | 5 | IPR020894 | |
| Domain | ConA-like_dom | 1.76e-03 | 219 | 147 | 7 | IPR013320 | |
| Domain | fn3 | 1.79e-03 | 162 | 147 | 6 | PF00041 | |
| Domain | CADHERIN_1 | 2.00e-03 | 113 | 147 | 5 | PS00232 | |
| Domain | Cadherin | 2.00e-03 | 113 | 147 | 5 | PF00028 | |
| Domain | FIBRINOGEN_C_1 | 2.00e-03 | 32 | 147 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.00e-03 | 32 | 147 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.00e-03 | 32 | 147 | 3 | PS51406 | |
| Domain | CADHERIN_2 | 2.08e-03 | 114 | 147 | 5 | PS50268 | |
| Domain | - | 2.08e-03 | 114 | 147 | 5 | 2.60.40.60 | |
| Domain | CA | 2.16e-03 | 115 | 147 | 5 | SM00112 | |
| Domain | Cadherin-like | 2.25e-03 | 116 | 147 | 5 | IPR015919 | |
| Domain | Cadherin | 2.42e-03 | 118 | 147 | 5 | IPR002126 | |
| Domain | IGc2 | 2.62e-03 | 235 | 147 | 7 | SM00408 | |
| Domain | Ig_sub2 | 2.62e-03 | 235 | 147 | 7 | IPR003598 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 9.00e-06 | 20 | 96 | 4 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.11e-05 | 21 | 96 | 4 | M27736 | |
| Pubmed | TANC2 TPP2 NHSL2 CNTNAP1 MPDZ GRIA1 NBEA SORBS1 ARMCX4 SMC2 MPRIP EEF2 PTPRD AGO3 PTPRS G3BP2 SYNE2 ZNF516 DCHS1 ARC SCRIB PARD3 KCNT1 | 3.99e-11 | 963 | 152 | 23 | 28671696 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 8.18e-08 | 3 | 152 | 3 | 31985401 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 8.18e-08 | 3 | 152 | 3 | 33656439 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 9784606 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 14967925 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 8524829 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 KIF26A PIEZO1 NLRX1 LMTK2 ATG2A PTCH1 WNK1 FAM83H MPRIP PCNX2 FASN CELSR1 TNRC18 PTPRF PTPRS ZNF516 ARC RIPOR1 | 3.98e-07 | 1105 | 152 | 19 | 35748872 |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 7.98e-07 | 17 | 152 | 4 | 19727691 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 10777529 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 22357843 | ||
| Pubmed | TANC2 TPP2 DENND2A PPP1R12B CNTNAP1 ACOT7 GRIA1 NBEA SORBS1 MAP7 PFKP SUCLA2 MPRIP FASN EEF2 LRIG1 CADPS PTPRS G3BP2 KNDC1 SCRIB | 1.21e-06 | 1431 | 152 | 21 | 37142655 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.31e-06 | 313 | 152 | 10 | 38270169 | |
| Pubmed | FLG FAM184B FAM114A1 PMPCB NHSL2 PCDHGA3 PPP1R12B GRIA1 ZBTB41 PFKP SMC2 MINDY2 RYR2 RFTN1 FASN EEF2 TNRC18 TCHHL1 SYNE2 CADPS2 PCDHGA8 | 1.37e-06 | 1442 | 152 | 21 | 35575683 | |
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 19273906 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 12376545 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 29073098 | ||
| Pubmed | 3.60e-06 | 274 | 152 | 9 | 34244482 | ||
| Pubmed | TPP2 PMPCB LEMD3 PPP1R12B LMTK2 NBEA SIX4 C2CD4C PTPRT RFTN1 PTPN11 PTPRD PTPRF WDR11 PTPRS SYNE2 SCRIB | 3.75e-06 | 1049 | 152 | 17 | 27880917 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DDX59 LEMD3 LMTK2 HNRNPUL1 MPRIP GTF2H4 WDR6 G3BP2 TBC1D12 SCRIB SLX4 | 4.11e-06 | 440 | 152 | 11 | 34244565 |
| Pubmed | 4.51e-06 | 8 | 152 | 3 | 37591863 | ||
| Pubmed | 4.51e-06 | 8 | 152 | 3 | 28637841 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 USP22 LMTK2 MPDZ SORBS1 HNRNPUL1 MAP7 PFKP WNK1 FAM83H MPRIP SYNE2 PLEKHA2 SCRIB PARD3 | 6.15e-06 | 861 | 152 | 15 | 36931259 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FKBP10 CAND2 PMPCB LEMD3 ACOT7 MPDZ SIX4 PFKP SMC2 FASN PTPN11 PTPRD PTPRF PTPRS WDR6 PKP3 | 6.22e-06 | 974 | 152 | 16 | 28675297 |
| Pubmed | FKBP10 FAM184B CAND2 PMPCB LEMD3 PIEZO1 MPDZ HNRNPUL1 MAP7 PFKP SUCLA2 ARMC1 MPRIP RAB3GAP1 COCH WDR11 WDR6 SYNE2 SCRIB PARD3 | 8.15e-06 | 1487 | 152 | 20 | 33957083 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | FKBP10 SYT12 INHBB WNK1 RFTN1 CLIP3 EEF2 RAB3GAP1 PTPN11 PTPRD WDR6 G3BP2 PLEKHA2 HEMK1 LRP5L RNASEH1 | 1.12e-05 | 1021 | 152 | 16 | 26760575 |
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 25624497 | ||
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 7832766 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 1.75e-05 | 12 | 152 | 3 | 9624153 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 18177725 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 8479755 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 28768764 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 36333288 | ||
| Pubmed | CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. | 1.90e-05 | 2 | 152 | 2 | 18022372 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 30536651 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 7665159 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 28883501 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 34984527 | ||
| Pubmed | Plakophilin 3 and Par3 facilitate desmosomes' association with the apical junctional complex. | 1.90e-05 | 2 | 152 | 2 | 34260281 | |
| Pubmed | Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. | 1.90e-05 | 2 | 152 | 2 | 20855507 | |
| Pubmed | Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome". | 1.90e-05 | 2 | 152 | 2 | 21884940 | |
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 1.90e-05 | 2 | 152 | 2 | 18495893 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22095531 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 9770300 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 9566880 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 25719439 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22718770 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 24813994 | ||
| Pubmed | DENND2A BRPF3 CAND2 KIF26A PIEZO1 PHRF1 LMTK2 ATG2A NPEPL1 ZNF516 KCNT1 | 2.29e-05 | 529 | 152 | 11 | 14621295 | |
| Pubmed | 2.88e-05 | 14 | 152 | 3 | 22653443 | ||
| Pubmed | 3.58e-05 | 15 | 152 | 3 | 20237282 | ||
| Pubmed | 3.58e-05 | 15 | 152 | 3 | 23863482 | ||
| Pubmed | Distinct Roles for Rac1 in Sertoli Cell Function during Testicular Development and Spermatogenesis. | 3.79e-05 | 43 | 152 | 4 | 32294451 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PMPCB HNRNPUL1 MAP7 PFKP FLG2 SMC2 FAM83H MPRIP FASN EEF2 GTF2H4 WDR11 WDR6 PKP3 G3BP2 SCRIB GAPDHS | 3.82e-05 | 1257 | 152 | 17 | 36526897 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SORBS1 PFKP CRK FAM83H MPRIP FASN EEF2 PKP3 PLEKHA2 SCRIB PARD3 | 4.16e-05 | 565 | 152 | 11 | 25468996 |
| Pubmed | 4.42e-05 | 376 | 152 | 9 | 24154525 | ||
| Pubmed | 5.32e-05 | 17 | 152 | 3 | 32155439 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 11802782 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 26050620 | ||
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 5.68e-05 | 3 | 152 | 2 | 28928464 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 11597768 | ||
| Pubmed | Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma. | 5.68e-05 | 3 | 152 | 2 | 31197031 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 26763980 | ||
| Pubmed | Secretory vesicle priming by CAPS is independent of its SNARE-binding MUN domain. | 5.68e-05 | 3 | 152 | 2 | 25437547 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 32437351 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 12659812 | ||
| Pubmed | An Alternative Exon of CAPS2 Influences Catecholamine Loading into LDCVs of Chromaffin Cells. | 5.68e-05 | 3 | 152 | 2 | 30389842 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 25703008 | ||
| Pubmed | Ca2+-dependent activator proteins of secretion promote vesicular monoamine uptake. | 5.68e-05 | 3 | 152 | 2 | 19008227 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 30642396 | ||
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 5.68e-05 | 3 | 152 | 2 | 25394468 | |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 5.68e-05 | 3 | 152 | 2 | 23403047 | |
| Pubmed | FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma. | 5.68e-05 | 3 | 152 | 2 | 32564009 | |
| Pubmed | Morphology, GluR1 and GRIP-C localization differ in octopus cells of C57BL6 and B6Cast mice. | 5.68e-05 | 3 | 152 | 2 | 12204345 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 14530279 | ||
| Pubmed | Protein-tyrosine phosphatase expression in pre-B cell NALM-6. | 5.68e-05 | 3 | 152 | 2 | 1370651 | |
| Pubmed | Role of the polarity protein Scribble for podocyte differentiation and maintenance. | 5.68e-05 | 3 | 152 | 2 | 22586490 | |
| Pubmed | 7.82e-05 | 405 | 152 | 9 | 38187761 | ||
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 7.96e-05 | 161 | 152 | 6 | 36398662 | |
| Pubmed | 8.24e-05 | 162 | 152 | 6 | 25826454 | ||
| Pubmed | 8.44e-05 | 101 | 152 | 5 | 10997877 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SYT12 CNTNAP1 PFKP SMC2 SUCLA2 FASN EEF2 G3BP2 PYGM GAPDHS PARD3 | 9.64e-05 | 621 | 152 | 11 | 22794259 |
| Pubmed | Phosphatidylinositol 4,5-bisphosphate optical uncaging potentiates exocytosis. | 1.13e-04 | 4 | 152 | 2 | 29068313 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 20633051 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 14516276 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 26231120 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 19238500 | ||
| Pubmed | RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. | 1.13e-04 | 4 | 152 | 2 | 15258163 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 24733394 | ||
| Pubmed | Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation. | 1.13e-04 | 4 | 152 | 2 | 24030498 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 28095473 | ||
| Pubmed | A SPRY1 domain cardiac ryanodine receptor variant associated with short-coupled torsade de pointes. | 1.13e-04 | 4 | 152 | 2 | 33664309 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 16687519 | ||
| Pubmed | TANC2 BRPF3 USP22 MTHFD2 PHRF1 MAP7 FAM83H ZNF469 SOWAHA AGO3 CADPS WDR6 SUPT7L SCRIB PARD3 | 1.19e-04 | 1116 | 152 | 15 | 31753913 | |
| Pubmed | 1.24e-04 | 58 | 152 | 4 | 31067491 | ||
| Pubmed | 1.25e-04 | 251 | 152 | 7 | 27507650 | ||
| Pubmed | TPP2 FKBP10 DDX59 CNTNAP1 HNRNPUL1 MAP7 PFKP WNK1 NPEPL1 FASN EEF2 WDR6 PKP3 SYNE2 PLEKHA2 ALPI | 1.88e-04 | 1297 | 152 | 16 | 33545068 | |
| Pubmed | 1.88e-04 | 5 | 152 | 2 | 35508126 | ||
| Pubmed | Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity. | 1.88e-04 | 5 | 152 | 2 | 36323321 | |
| Pubmed | 1.88e-04 | 5 | 152 | 2 | 22111578 | ||
| Cytoband | 1p34 | 1.64e-04 | 32 | 152 | 3 | 1p34 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.37e-06 | 21 | 91 | 4 | 813 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 4.25e-06 | 7 | 91 | 3 | 1350 | |
| GeneFamily | Fibronectin type III domain containing | 1.57e-04 | 160 | 91 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-04 | 161 | 91 | 6 | 593 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.32e-03 | 43 | 91 | 3 | 409 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.21e-03 | 181 | 91 | 5 | 694 | |
| GeneFamily | Cadherin related | 3.24e-03 | 17 | 91 | 2 | 24 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 3.24e-03 | 17 | 91 | 2 | 1059 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-07 | 184 | 152 | 8 | b8ecf58b3bdb25bcba5efc2d764930bb84ab95c8 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-07 | 184 | 152 | 8 | b232a9cc1d14e1a134b037016d437b93921a4a0f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.43e-07 | 193 | 152 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.43e-07 | 193 | 152 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-07 | 194 | 152 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.71e-07 | 195 | 152 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-07 | 196 | 152 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 4.16e-07 | 198 | 152 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-06 | 174 | 152 | 7 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 179 | 152 | 7 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-06 | 186 | 152 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.73e-06 | 187 | 152 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.14e-06 | 190 | 152 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-06 | 191 | 152 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.28e-06 | 191 | 152 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.43e-06 | 192 | 152 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.59e-06 | 193 | 152 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.74e-06 | 194 | 152 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.91e-06 | 195 | 152 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.91e-06 | 195 | 152 | 7 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.91e-06 | 195 | 152 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.91e-06 | 195 | 152 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.42e-06 | 198 | 152 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.42e-06 | 198 | 152 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.42e-06 | 198 | 152 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.42e-06 | 198 | 152 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 198 | 152 | 7 | 27f0654fb0857e93f030e1a4b1c307b31576bbcd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 198 | 152 | 7 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.61e-06 | 199 | 152 | 7 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.61e-06 | 199 | 152 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.61e-06 | 199 | 152 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-06 | 199 | 152 | 7 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.79e-06 | 200 | 152 | 7 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.79e-06 | 200 | 152 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.79e-06 | 200 | 152 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.79e-06 | 200 | 152 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.37e-06 | 136 | 152 | 6 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-06 | 143 | 152 | 6 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-05 | 154 | 152 | 6 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.61e-05 | 156 | 152 | 6 | 96747447ba7dc2c10079cee44394b19ce60b2f41 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.14e-05 | 164 | 152 | 6 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-05 | 165 | 152 | 6 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-05 | 166 | 152 | 6 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 167 | 152 | 6 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 167 | 152 | 6 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.53e-05 | 169 | 152 | 6 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.62e-05 | 170 | 152 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 174 | 152 | 6 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 174 | 152 | 6 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-05 | 174 | 152 | 6 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 175 | 152 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 175 | 152 | 6 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 176 | 152 | 6 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-05 | 177 | 152 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-05 | 177 | 152 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 178 | 152 | 6 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 178 | 152 | 6 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 178 | 152 | 6 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.50e-05 | 179 | 152 | 6 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-05 | 183 | 152 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 184 | 152 | 6 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-05 | 185 | 152 | 6 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 4.20e-05 | 185 | 152 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-05 | 185 | 152 | 6 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | BAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 4.20e-05 | 185 | 152 | 6 | e867ed55ab0df018f14bca824da09d36d83e12f9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.46e-05 | 187 | 152 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-05 | 187 | 152 | 6 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.46e-05 | 187 | 152 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-05 | 187 | 152 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-05 | 187 | 152 | 6 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-05 | 188 | 152 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.73e-05 | 189 | 152 | 6 | f0418851ad4042c4cd87c8729e4f0d43bdf8fccb | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 189 | 152 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 189 | 152 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.87e-05 | 190 | 152 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 191 | 152 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 152 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.02e-05 | 191 | 152 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 152 | 6 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-05 | 192 | 152 | 6 | 7ccdb977320d09f21e70e7718ead73eeb56d0c48 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-05 | 192 | 152 | 6 | f206c015f091234e2c86dfa66926e97b2ea99690 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.17e-05 | 192 | 152 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-05 | 192 | 152 | 6 | 69963e8dc6d6368243e61da133484eb23225625a | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-05 | 192 | 152 | 6 | bfc68af68fdb99ddfe4add49671e4b4c26e6f962 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.32e-05 | 193 | 152 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 5.32e-05 | 193 | 152 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.32e-05 | 193 | 152 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.32e-05 | 193 | 152 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.47e-05 | 194 | 152 | 6 | d8f367beab16a3186821e42311947b6c9e99978c | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 194 | 152 | 6 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.47e-05 | 194 | 152 | 6 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 6.53e-06 | 8 | 146 | 3 | C3891448 | |
| Disease | azoospermia (implicated_via_orthology) | 3.18e-04 | 27 | 146 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy (disorder) | 3.60e-04 | 6 | 146 | 2 | C0699743 | |
| Disease | peeling skin syndrome (is_implicated_in) | 3.60e-04 | 6 | 146 | 2 | DOID:0060283 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.03e-04 | 447 | 146 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.32e-04 | 71 | 146 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | risk-taking behaviour | CDSN KIF26A CDH23 GRIA1 PTCH1 RYR2 MSRA TNNI3K PTPRF CADPS CADPS2 TNXB | 4.35e-04 | 764 | 146 | 12 | EFO_0008579 |
| Disease | hereditary lymphedema (is_implicated_in) | 5.02e-04 | 7 | 146 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | joint hypermobility measurement | 5.81e-04 | 33 | 146 | 3 | EFO_0007905 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 6.68e-04 | 8 | 146 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | disease recurrence, malaria | 6.68e-04 | 8 | 146 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | glioblastoma (implicated_via_orthology) | 8.56e-04 | 9 | 146 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | vital capacity | FAM184B DENND2A CAND2 PIEZO1 SIX4 PTCH1 ADCY3 MAGEF1 RYR2 PTPRD LOXL1 FOLH1B RIPOR1 PARD3 TNXB | 1.24e-03 | 1236 | 146 | 15 | EFO_0004312 |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 1.27e-03 | 43 | 146 | 3 | EFO_0007788, EFO_0008343 | |
| Disease | Cognitive impairment | 1.30e-03 | 11 | 146 | 2 | HP_0100543 | |
| Disease | selective IgA deficiency disease | 1.54e-03 | 46 | 146 | 3 | EFO_1001929 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | estradiol measurement | 2.21e-03 | 110 | 146 | 4 | EFO_0004697 | |
| Disease | Drug habituation | 2.60e-03 | 115 | 146 | 4 | C0013170 | |
| Disease | Drug abuse | 2.60e-03 | 115 | 146 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.60e-03 | 115 | 146 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.60e-03 | 115 | 146 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.60e-03 | 115 | 146 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.60e-03 | 115 | 146 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.60e-03 | 115 | 146 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.60e-03 | 115 | 146 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.60e-03 | 115 | 146 | 4 | C0029231 | |
| Disease | Substance abuse problem | 2.68e-03 | 116 | 146 | 4 | C0740858 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 3.53e-03 | 18 | 146 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | optic disc size measurement | 3.61e-03 | 205 | 146 | 5 | EFO_0004832 | |
| Disease | lysophosphatidylcholine 20:5 measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0010364 | |
| Disease | glaucoma (is_marker_for) | 4.36e-03 | 20 | 146 | 2 | DOID:1686 (is_marker_for) | |
| Disease | exercise test | 4.36e-03 | 20 | 146 | 2 | EFO_0004328 | |
| Disease | response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement | 4.36e-03 | 20 | 146 | 2 | EFO_0803359, EFO_0803362 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 4.36e-03 | 20 | 146 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | eye morphology measurement | 4.67e-03 | 218 | 146 | 5 | EFO_0007858 | |
| Disease | disease of metabolism (implicated_via_orthology) | 4.80e-03 | 21 | 146 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | breast size | 4.90e-03 | 69 | 146 | 3 | EFO_0004884 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TNGGAEPRLGFSDIH | 256 | O60347 | |
| RPDDANVAGNVHGGT | 61 | O00154 | |
| HAAAGPDGQLGTVEQ | 31 | Q6ZT62 | |
| QDVEGHGVNPSVSGL | 106 | Q8IWD4 | |
| TVVQHGGPDAVTLRG | 631 | Q9BZ76 | |
| RPGHTTVSAGGVLND | 246 | P78357 | |
| VENRVGGVHTVGDSG | 96 | Q8NHS2 | |
| SESARHTVSVGVGGP | 141 | Q7LC44 | |
| LFGQHGEREPSSGDV | 311 | Q99678 | |
| QDKAVSRVGSHPEGG | 251 | Q9NVT9 | |
| RVLENGEDHGVAGSP | 946 | Q9ULD4 | |
| VSSGLVRGSHGEPDA | 2776 | Q9NYQ6 | |
| ASQDGQDTIRGHPGS | 1481 | P20930 | |
| ASQEGQDTIRGHPGS | 3426 | P20930 | |
| AEGSHVSGQSNGRDP | 826 | Q9H9G7 | |
| VVDQHGSGAPGVVQG | 256 | Q15517 | |
| NIGPTEDVQASAHGG | 101 | Q6IC83 | |
| ESGQARGEHTVHVGP | 291 | Q8TF44 | |
| EAIDNGPVGKRHTGT | 1071 | Q9H251 | |
| GAGTRHSAQPQIVAG | 1021 | Q5H9R4 | |
| VRVEHSPGDGERGVA | 176 | Q2TAZ0 | |
| SVSALIGGNQEGSHP | 196 | P46108 | |
| GHRESPGALVETSAG | 31 | Q8TBN0 | |
| GQDQAHQAGETGPTV | 106 | Q9UBG7 | |
| EQPEVLVTGAGRGHA | 876 | Q15042 | |
| RAGTHQGPLDAETEV | 241 | Q86UR1 | |
| VEGEAVQNGPASHSR | 531 | Q14699 | |
| QDSGGRLVGVPASHF | 726 | Q9Y5G5 | |
| AGTEPGRHPQAVAAV | 36 | A4D126 | |
| HGFGPITTDIREGQT | 186 | Q9UJ68 | |
| NHIGGGAFSVDSPRI | 391 | Q9Y2U8 | |
| TQFPSEEAREGGGVH | 21 | Q7L1V2 | |
| HGNRPDGIGTVTVEE | 761 | Q9ULU8 | |
| GPRIVLAAAGGVSHD | 236 | O75439 | |
| AEGAGERHVTITGSP | 281 | P57723 | |
| VVQARDGGAHPELGS | 331 | Q96JQ0 | |
| PIVSPRAVHAGGTNG | 2086 | Q96JQ0 | |
| SIVPERHGTTHGQTG | 1686 | Q5D862 | |
| SAGRSVHGGVPQNVS | 91 | Q12891 | |
| AQERVGGVGPADTHE | 556 | Q6WCQ1 | |
| GGHDGETRAPTASQE | 21 | Q9HAY2 | |
| HRGGDGAVRSETAPD | 11 | Q14244 | |
| VVRTEGGPQANGHIE | 856 | Q96JA1 | |
| FTQVEATRGGGHPAR | 106 | Q7RTR2 | |
| EEVAQRSHAVGSPGS | 146 | Q9Y5R4 | |
| DVHGEQETEGRSSPG | 241 | O60303 | |
| LDGHASPGADGQERV | 126 | P09529 | |
| SVEGPLTGHGESIQD | 1436 | Q2LD37 | |
| DHIIATEERGGPGQA | 776 | Q9ULE4 | |
| DLQGTEHRPTQSGGG | 656 | Q5JUK3 | |
| VGSDTVRGQARHPFG | 106 | Q08397 | |
| GGQLAEVHSVSPEQG | 66 | Q5T1V6 | |
| GGTASLEEGPQHVTV | 461 | Q86VH2 | |
| ESSAEQPRKGGAQHG | 1906 | A6NKB5 | |
| VLHSAQGATLGGPEE | 16 | P60985 | |
| AAPVHAGERATGFGV | 466 | Q8NDH3 | |
| GHVQRGGTPSAFDRI | 306 | Q01813 | |
| GGIDPQSGAAVVHET | 76 | Q9HBA9 | |
| RETDFGVGVRDHPGQ | 51 | E9PQR5 | |
| GDHVNIAVQVRGGPS | 206 | Q8WX77 | |
| GGRRDAAPAHGQSIE | 691 | Q9P1Y6 | |
| KVVGTNPHADRNGGA | 216 | A4QPB2 | |
| GHDSGVNVGEERPPT | 1591 | Q9ULI4 | |
| PVIVISDAGDGHRGT | 1071 | Q8IWU2 | |
| GHRGTEVTPETFTAG | 1081 | Q8IWU2 | |
| DAGPVVVHCSAGIGR | 451 | Q06124 | |
| GGSGVSATPAQRDHL | 336 | Q86UT6 | |
| HVEVGSQAGADGTRP | 61 | Q5BKU9 | |
| DAGPIVVHCSAGVGR | 1581 | Q13332 | |
| EAGPIVVHCSAGAGR | 1076 | O14522 | |
| EGQGQTASHGELLTP | 326 | Q14012 | |
| HGGEDVAVFARGPQA | 451 | P09923 | |
| VLVASDGGDPVHSGN | 211 | Q9Y5H0 | |
| RTEDDGVGPRGAHVS | 161 | P78367 | |
| AHGESGARGVPGSAV | 461 | Q96AY3 | |
| GGGSGSEVSQRVHPS | 206 | Q9ULE3 | |
| GHRSIPGVAIDGENN | 386 | P57773 | |
| VHGGVDASGKPQEAV | 41 | Q9UN86 | |
| GAQGPSRVEEAEGHT | 351 | Q96BT3 | |
| EAGGIPGRVHISQST | 446 | O60266 | |
| HGNRPDGIGTVSVEE | 726 | Q86UW7 | |
| VVAPVNIHGGGGSRS | 701 | Q9UQ52 | |
| GVAPGDVTLVVGTHG | 101 | A4D2B0 | |
| TPGHGGQRDVSVVVA | 166 | A4D2B0 | |
| SARGAQPTVEAGVAH | 966 | O75064 | |
| PVRNGESHSREGLAG | 266 | Q76NI1 | |
| ADAIHRGGGQIIPTA | 711 | P13639 | |
| APSGQEREDHGLETG | 81 | Q8IXQ3 | |
| DQPTGKHDGSVFGVR | 451 | Q96DZ5 | |
| RDPGGGAGAITVASH | 746 | Q6ZRV2 | |
| GSGENGRVVSHDFPK | 871 | P42261 | |
| VDGGINPDSLRGTHT | 91 | P49327 | |
| GRGAHQNIIPASTGA | 271 | O14556 | |
| SLAEVGQVAGPGHQR | 846 | O75155 | |
| AAVHRGVISNSGGPV | 76 | O43405 | |
| GIGTEGPHVGLVQAS | 196 | O43405 | |
| EGSLHARDPVGGTTE | 1801 | Q92736 | |
| RETDFGVGVRDHPGQ | 51 | E9PJ23 | |
| DGVAGEHSQIPNGSR | 216 | Q9UKN5 | |
| DPAVASRGGQLHAAG | 96 | C0HLS1 | |
| RIHGVNSGSSEGAQP | 161 | Q8IWE2 | |
| QDGPITVHCSAGVGR | 1831 | P10586 | |
| DNSRVEPVGHADTGL | 246 | Q8TEW0 | |
| QDGPISVHCSAGVGR | 1836 | P23468 | |
| RPGHINEEVETEGGS | 56 | Q9BUJ2 | |
| SPETAVAGVGHELGT | 111 | Q8NBR6 | |
| GRHGTAAEEGAQERP | 756 | Q9BVN2 | |
| DGQEGSEPGSHTILR | 166 | Q9HB19 | |
| SSDGRGDNVGHVIIG | 376 | Q8IV01 | |
| GDNVGHVIIGPSASG | 381 | Q8IV01 | |
| PEGQDVTSGFSRIGH | 191 | Q32P41 | |
| EGTITTSENRGGDPH | 1051 | Q8WXH0 | |
| VPEGVHGRVAVGQDA | 321 | Q5HYW2 | |
| DGAHERPGGDATVTI | 216 | P13995 | |
| DILGNSDRPGSGVHV | 1036 | Q8NFP9 | |
| GAQIIGGHEVTPHSR | 31 | Q6UWY2 | |
| GAGGPAHQVIVEATE | 1246 | Q13635 | |
| AHREVAGGAAVGLSP | 31 | Q9UIU6 | |
| GASGDGVRTETAPHI | 11 | Q2M3M2 | |
| GIVGDGRPVQHVQAS | 1666 | Q9HCD6 | |
| PQESEEGNVSGHGVL | 346 | O94864 | |
| TPANFLDVGGGATVH | 341 | Q9P2R7 | |
| SEPAHSVNGEGGVLA | 131 | Q8IY92 | |
| PAGSTGQVVHGSPRE | 101 | O75339 | |
| GAGGTVHQPGFIVVE | 296 | Q92759 | |
| VPGHSGFIGNEEADR | 261 | O60930 | |
| PVSFHERGGVGSRAD | 161 | Q9Y446 | |
| REGSGAQGEAEVRHP | 666 | O15417 | |
| TGTLIQGHEPEAGEA | 86 | Q92618 | |
| GTNVVSEPREEGSAH | 101 | Q9BZV1 | |
| GRESSVNGESHIPGI | 246 | A6NNY8 | |
| LSPGSEGNVVNGESH | 341 | Q9UPT9 | |
| AGGDVSVVTGHQQEP | 1946 | O75970 | |
| ASADIVVGGVAHGRP | 71 | Q6UVY6 | |
| AIGDVVNHDPAVGDR | 626 | P11217 | |
| RSGAPVDVNARSHGG | 371 | Q2M3V2 | |
| EAGDSVGNVHEGLTP | 336 | Q5SVQ8 | |
| PGSEAEQTERHRGGE | 1186 | Q9BX66 | |
| HGGQRVGPVSAVGLT | 2266 | P22105 | |
| AVRVPGHEDGVTISG | 2671 | P22105 | |
| GLHEGQRVGPVSTVG | 3236 | P22105 | |
| RDPVQVAAPSDHGVG | 536 | P29144 | |
| GVDVSRVADHGPGLA | 426 | P48067 | |
| PGLTAHVVSAGGRAE | 796 | Q9NNW5 | |
| VFDPHGTLSGGARSQ | 656 | O95347 | |
| GEHERPGGDATVTIA | 231 | Q9H903 | |
| ENGVSPGGTDNHASV | 1976 | Q96JG9 | |
| REQHPGSGEEAVALV | 106 | O14771 | |
| EGPEEAAAGRSHVVQ | 1491 | Q92508 | |
| EEVNTGRQEGSEAPH | 661 | P52746 | |
| GGDQTHPELEGTAVS | 451 | Q5QJ38 | |
| DGNENVPSSSGRHEG | 1081 | Q9H4A3 | |
| IGQSAIAGEEHPRGS | 431 | Q9BZH6 | |
| QSFAGVLGSHERGPS | 21 | Q6ZS17 | |
| ADVNVSGEVGDRPLH | 191 | Q59H18 | |
| NGAGGTTLAVLHPER | 81 | Q6DKI7 | |
| GTEQSGTGNRHPAQE | 641 | Q6ZVT0 | |
| RGTVHSQGEPSGHRE | 136 | Q9BZD7 | |
| DSIGQGEVLAHGSPS | 451 | Q702N8 | |
| GEVLAHGSPSREEGT | 456 | Q702N8 | |
| GSGLGAVVSQHPSRV | 11 | A0A075B6N2 | |
| HRTEENVTGEQGGPD | 131 | Q9UQQ1 | |
| HGASVGIVNSEGEVP | 146 | O60237 |